S

Sarepta Therapeutics

D
SRPT
USD
1.96
(1.5667%)
Market Closed
22,470.00
Volume
1.9
EPS
-
Div Yield
169.413
P/E
12,117,246,398.04
Market Cap
Today
1.5667%
1 Week
1.405%
1 Month
-7.505%
6 Months
2.443%
12 Months
6.692%
Year To Date
31.873%
All Time
0%

Title:
Sarepta Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.
Do you need help or have a question?